I.M. Sechenov First Moscow State Medical University (Sechenov University)

Status Completed

Clinical Trial Summary

Single-institution uncontrolled open-label trial.

Clinical Trial Description

The single-institution uncontrolled open-label trial is to optimize the anticoagulant therapy in the out-patient practice. The study embraces patients who are advised to take the anticoagulant therapy for some reasons. The study has two phases - a retrospective part and a concurrent part. At the first phase, researchers analyze the compliance with the anticoagulant therapy in the real clinical practice. At the concurrent phase, researchers conduct a single-institution uncontrolled open-label trial to evaluate the effectiveness, safety of the anticoagulant therapy and compliance with it at the antithrombotic therapy control ward, and estimate the glomerular filtration rate in patients taking the anticoagulant therapy. ;

Study Design

Related Conditions & MeSH terms

Anticoagulants

Clinical Trial Details

NCT number	NCT05319340
Study type	Interventional
Source	I.M. Sechenov First Moscow State Medical University
Contact
Status	Completed
Phase	N/A
Start date	January 15, 2014
Completion date	March 2, 2021

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02128841` - Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.	Phase 2
Recruiting	`NCT03666962` - Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation
Recruiting	`NCT03670446` - Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants：A Study on Behavioral Patterns	N/A
Recruiting	`NCT04796714` - AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE	Phase 4
Completed	`NCT01033279` - Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy	N/A
Completed	`NCT00287313` - Daily Vitamin K in Patients on Warfarin With Unstable INRs	N/A
Completed	`NCT00222638` - Influenza Vaccination and Oral Anticoagulant Therapy	Phase 4
Active, not recruiting	`NCT06203795` - Dialysis Performance of the FX CorAL Membrane	N/A
Completed	`NCT03864900` - Efficacy of a Health Belief Model Based Intervention for Anticoagulation Adherence	N/A
Not yet recruiting	`NCT04977076` - Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention	N/A
Recruiting	`NCT04861103` - Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)	Phase 4
Completed	`NCT01653405` - Improving Anticoagulation Control in VISN 1	N/A
Not yet recruiting	`NCT05820854` - Self-care and Self-efficacy Scale in Oral Anticoagulation Therapy
Completed	`NCT04681482` - Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare
Not yet recruiting	`NCT06137794` - Application of "I-Anticoagulation"in Patients With Atrial Fibrillation	N/A
Completed	`NCT02103101` - Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events	N/A
Active, not recruiting	`NCT05065502` - MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings	N/A
Recruiting	`NCT03965208` - Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation	Phase 4
Completed	`NCT03318393` - Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO	Phase 4
Recruiting	`NCT03288441` - Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia